Colon cancer screening and surveillance in inflammatory bowel disease.

Colon cancer screening and surveillance in inflammatory bowel disease.

Item
http://www.wikidata.org/entity/Q38288038
Introducing vedolizumab to clinical practice: who, when, and how?A Comprehensive Meta-Analysis of MicroRNAs for Predicting Colorectal Cancer.Risk factors for developing colorectal cancer in Japanese patients with ulcerative colitis: a retrospective observational study-CAPITAL (Cohort and Practice for IBD total management in Kyoto-Shiga Links) study IThe continuing uncertainty about cancer risk in inflammatory bowel disease.Tianfoshen oral liquid: a CFDA approved clinical traditional Chinese medicine, normalizes major cellular pathways disordered during colorectal carcinogenesis.Circulating DNA and its methylation level in inflammatory bowel disease and related colon cancer.Interval colorectal carcinoma: An unsolved debate.Cancer Risk in Patients with Intestinal Behçet's Disease: A Nationwide Population-Based Study.Getting a Low Grade for Missing High-Grade Dysplasia and Colorectal Cancer in IBD.Interaction analysis of IL-12A and IL-12B polymorphisms with the risk of colorectal cancer.
P2860

Colon cancer screening and surveillance in inflammatory bowel disease.

Item
http://www.wikidata.org/entity/Q38288038
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Colon cancer screening and surveillance in inflammatory bowel disease.
@en
type
label
Colon cancer screening and surveillance in inflammatory bowel disease.
@en
prefLabel
Colon cancer screening and surveillance in inflammatory bowel disease.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Colon cancer screening and surveillance in inflammatory bowel disease
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932